We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.14 | 2.10 | 2.18 | 2.20 | 2.19 | 2.19 | 604,698 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/12/2017 15:45 | I first became aware of IMM back at the beginning of 2015 due to niece having Lupus and me looking into new treatments for her. I invested quite heavily in the low 20's because I was very impressed with the science behind Lupuzor and was even more happy to be able to read extremely knowledgeable posts from quite a few users on this board. It's a shame it's gone downhill so much recently with multiple id users posting the same over and over again. All of which can be found in the header. Really happy to see SK is still around and hope still some of the other more knowledgeable posters are also still around. | jwoolley | |
07/12/2017 15:42 | Money maker. What is your objevtive on posting the £80 a share ramping? To encourage those others to buy? If anything went wrong, I hope you would be as quick to put your hand in your pocket to compensate anyone who bought shares based on your postings here? | hamhamham1 | |
07/12/2017 15:40 | SK, you've already completed a sterling effort at educating us on the potential here, so you're allowed a rest from posting. Especially now that everything is now locked and loaded. Actually a rest from the immoderate short term claims here may be beneficial | nigsrodders | |
07/12/2017 15:30 | hhh - just filter all the ramptastic posters and your screen will be much more readable | ewads | |
07/12/2017 15:29 | Do repeat. Doubters need it. | greedfear | |
07/12/2017 15:27 | Says the person who posted eight times today without adding anything useful. | money maker1 | |
07/12/2017 15:19 | Money maker. Isn't that the 3rd time in a row you have posted that exact same blurb? If you haven't got anything new to say then please refrain from repeating. | hamhamham1 | |
07/12/2017 15:15 | They only need 80,000 patients at $25,000 pa to get to $2 billion revenues. More likely to be multiples of that imo. | hottingup | |
07/12/2017 15:08 | IMM could have the Phase III Lupuzor (P140, Forigerimod) results within 5 or 6 weeks. If you take Tim McCarthy's recent reference to Lupuzor being a "multi-billion drug" as meaning lupus sales of at least $2 billion pa, then reading across from Gilhead's recent cash buyout of Kite for $11.9 billion in expectation of year 2022 sales of $1.7 billion, that implies the value of $2 billon pa Lupuzor sales for lupus would give a buyout price for IMM of at least $13.99 billion or £80 a share. The figure goes up even more if you add in other indications for Lupuzor P140, of which there are at least 10. money maker1 5 Dec '17 - 18:43 - 6803 of 6811 6 0 Edit If Gilead paid $11.9 billion cash in 2017 to acquire Kite's axi-cel on predicted sales of $1.7 billion by 2022, Lupuzor could be worth a lot more for lupus and the 10+ other indications it could address. Deals like this just prove the value of Lupuzor if the Phase 3 results are successful. This is not ramping just rational analysis. Tim McCarthy (IMM Chairman) Presentation, 14/3/2017: "There's going to be a fantastic return on investment for anybody who invests in ImmuPharma...This (Lupuzor) is going to be a multi-billion dollar drug, its as simple as that...This will absolutely be a multi-billion dollar drug." 4 min 40 sec. Its not just me saying this. Its IMM themselves and precedents for such valuations are emerging all the time in the sector. | money maker1 | |
07/12/2017 14:38 | I still read the boards regularly, but there is not much to post about at the moment and I am very busy at present. | sicilian_kan | |
07/12/2017 14:28 | hmmm guess SK is long gone, or maybe only holding a very small amount not worth firing the PC up for. WJ. | w1ndjammer | |
07/12/2017 14:25 | Buzzer, do you want me to pm you with any snippets? Lol! | alphapig | |
07/12/2017 14:24 | bazzer, I've never had the follow thread ticked as most boards get too much traffic for it to be worthwhile...better to check in a couple of times a day or so, or if it truly is a sit back - just once a day once you've seen any news released. I couldn't not check in at some point just in case a trading hours rns pops up | sportbilly1976 | |
07/12/2017 14:13 | Ive taken immupharma off my follow thread, sick of getting a email with every bb post, before there was a great crowd with great knowledge, especially sk and you could learn a lot, the new crowd since october are all rampers, We all want success and to make money but ill wait for the rns, and results. Enjoy your sky high estimates, | bazzer13 | |
07/12/2017 13:26 | Homebrew, and perhaps ask Lisa if she's considering a large purchase just before results rns', nudge nudge wink wink, get off me barra! | alphapig | |
07/12/2017 13:11 | If they have preliminary results soon after, then it would suggest less ambiguity with the results. That would send a strong signal, the safety data alone should help with this mind you. | l0ngterm | |
07/12/2017 13:09 | L0ngterm I was hoping for one this week if at all. When I messaged them last they said they would announce the trial had completed early in January so I was hoping they might have released something about now saying all on track with 1 month to go. I would recommend emailing Lisa at the company lisa.baderoon@immuph | homebrewruss | |
07/12/2017 13:09 | ny, I think bitcoin will go to $30k at least. Its now seen as a safe haven. Today spike is Jerusalem. The market capital is only about $400bn compared with gold of about $6tn. So bitcoin 15 times small smaller and therefore will exaggerate more as investment piles in. What ever floats your boat I suppose. Even platforms like city index are now doing spreadbetting and cfd's for bitcoin. So many more investors will find easy access to trade it. So its gonna fly up I think but what goes up.... | hamhamham1 | |
07/12/2017 13:06 | I think they will RNS when the last patient receives their final dose. Remember, they also said they would have preliminary results soon afterwards.......the H | herschel k | |
07/12/2017 13:06 | Its pure bubble now...it has gone from $9,000 to $15,000 in a WEEK! It's a currency, so no news as such to drive the price 50% in a week, just speculators and people fearing they have missed out and buying now As it is used to purchase items/services - just this not recreate hyperinflation, only in a virtual sense? Ethereum by contrast has moved from $327 to $425 since Sept 8th | sportbilly1976 | |
07/12/2017 13:04 | Folks what your thoughts on an rns soon?I expected one this week to be honest, but do you think the company is leaving it till next week as a higher number of patients would of completed dosing?Or do you think the next update will be in January? | l0ngterm | |
07/12/2017 13:00 | Looks like they want some sellers, bid ticking up with no trades shown. | alphapig | |
07/12/2017 12:57 | Ticking higher each day as we close in on end of January, perhaps earlier, not a stock to be out of as we get this close, just buy & hold GLA | ny boy | |
07/12/2017 12:56 | spmc, for that I gave you a tick down lol All good fun, it’s a one way bet, who dares to short it yet, crazy will eventually collapse 75% still wtf do I know I told my son to sell a few of his coins at 5500 lol He’s holding from 2200 | ny boy | |
07/12/2017 12:55 | Everytime an rns of value is released we see a 15 to 30 percent increase. Followed by a settlement of about 5 percent. Have your holdings, contra smart contra hard | immy1992 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions